Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma - Related Studies

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

This study has been completed.

Study NCT00078637. Last updated on August 23, 2007. Information provided by Eisai Medical Research Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neoplasms
		Lymphoma, Malignant

2	Additional conditions recognized in this trial
		Lymphoma

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		E7820

5	Sponsors listed in this trial
		Eisai Medical Research Inc.